ArticleJournal of cancer research and clinical oncology2022

The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study.

Emre Yekedüz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.